Heart Sense

📍 Suchy Las, Poland🗓 Founded 2019👥 3 employees💰 Last funded Aug 2019
Biotechnology Research🌐 heartsense.pl
Website LinkedIn
Heart Sense is a team led by dr Grzegorz Suwalski, which has set itself the goal of increasing the effectiveness and safety of coronary artery bypass surgery - this is the most commonly performed cardiac surgery in the world - in 2016, a total of 833,000. The team is developing an innovative device recording electrocardiographic (ECG) signal directly from the surface of the beating heart. Scientific data and clinical practice indicate that the introduction of such a device will bring benefits to patients (reduction in the number of complications), doctors (facilitation of surgery) and will be more economical (less invasive and cheaper operations). The electrode, which is a key element of the device, will have the form of a "petal" having the ability to connect to the surface of the heart. It will be produced in technology enabling the production of cheap, single-use items.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
Poland
1
Frequently asked questions
Who invested in Heart Sense?
Heart Sense has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Heart Sense last raise funding?
The most recent investment in Heart Sense recorded on gritt.io was in August 2019.
When was Heart Sense founded?
Heart Sense was founded in 2019.
What industry is Heart Sense in?
Heart Sense operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Heart Sense based?
Heart Sense is headquartered in Suchy Las, Poland.